ETH-47

N/A

Report date: 2025/07/15 20:00:07
First In Class

Base Information

Drug NameETH-47
Drug Alias NameETH-47ETH47
ClassificationCell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionInterferon type Ⅲ modulators
TargetsInterferon lambda
Therapy Area/IndicationsInfluenza A virus infectionsCoronavirus Disease 2019 (COVID-19)Asthma +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEthris GmbH
China Registration ClassN/A

Develop Information

Active CompaniesEthris GmbH
Inactive CompaniesN/A
Active IndicationsAsthmaRespirovirus Infections
Inactive IndicationsInfluenza A virus infectionsCoronavirus Disease 2019 (COVID-19)Respiratory Tract Infections

Other Information

ATC CodeN/A
Related LinksN/A